medsurfnews - ostetricia e ginecologia - guideline on the treatment of premenstrual dysphoric disorder (pmdd)

Ostetricia e Ginecologia

Guideline on the treatment of premenstrual dysphoric disorder (PMDD)

There are substantial research data available to support premenstrual dysphoric disorder (PMDD) as a diagnostic entity of a severe form of premenstrual disorder, which causes clinically relevant functional impairment and requires treatment. The European Medicines Agency document should be conceived as general guidance, and should be read in conjunction with other applicable EU and ICH guidelines.
Approfondisci

http://www.ema.europa.eu/ema/pages/includes/document/open_do...

EMA - European Medicines Agency

Ultime risorse da EMA - European Medicines Agency

Towards a robust global framework for conduct and oversight of clinical trials (Ricerca e sperimentazione)
European Medicines Agency recommends suspension of marketing authorisations for meprobamate-containing medicines in the European Union (Medicina generale)
Guideline on the treatment of premenstrual dysphoric disorder (PMDD) (Ostetricia e Ginecologia)
Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials (Informatica Medica)
Risk-based quality management in clinical trials, draft (Statistica)
Visualizza tutte le risorse di EMA - European Medicines Agency